Matthews PM - Search Results

1

Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.

Bishop CA, Newbould RD, Lee JS, Honeyfield L, Quest R, Colasanti A, Ali R, Mattoscio M, Cortese A, Nicholas R, Matthews PM, Muraro PA, Waldman AD. Bishop CA, et al. Among authors: matthews pm. Neuroimage Clin. 2016 Nov 9;13:9-15. doi: 10.1016/j.nicl.2016.11.005. eCollection 2017. Neuroimage Clin. 2016. PMID: 27896065 Free PMC article.

2

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.

Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Evangelou N, et al. Among authors: matthews pm. Ann Neurol. 2000 Mar;47(3):391-5. Ann Neurol. 2000. PMID: 10716264

3

Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.

Stevenson VL, Smith SM, Matthews PM, Miller DH, Thompson AJ. Stevenson VL, et al. Among authors: matthews pm. J Neurol. 2002 Feb;249(2):171-7. doi: 10.1007/pl00007860. J Neurol. 2002. PMID: 11985382

4

Cerebral plasticity in multiple sclerosis: insights from fMRI.

Cifelli A, Matthews PM. Cifelli A, et al. Among authors: matthews pm. Mult Scler. 2002 May;8(3):193-9. doi: 10.1191/1352458502ms820oa. Mult Scler. 2002. PMID: 12120689 Review.

5

White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.

Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM. Parry A, et al. Among authors: matthews pm. J Neurol. 2002 Sep;249(9):1279-86. doi: 10.1007/s00415-002-0837-7. J Neurol. 2002. PMID: 12242554

6

Thalamic neurodegeneration in multiple sclerosis.

Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Cifelli A, et al. Among authors: matthews pm. Ann Neurol. 2002 Nov;52(5):650-3. doi: 10.1002/ana.10326. Ann Neurol. 2002. PMID: 12402265

7

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.

Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N. Smith SM, et al. Among authors: matthews pm. Neuroimage. 2002 Sep;17(1):479-89. doi: 10.1006/nimg.2002.1040. Neuroimage. 2002. PMID: 12482100

8

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.

Wylezinska M, Cifelli A, Jezzard P, Palace J, Alecci M, Matthews PM. Wylezinska M, et al. Among authors: matthews pm. Neurology. 2003 Jun 24;60(12):1949-54. doi: 10.1212/01.wnl.0000069464.22267.95. Neurology. 2003. PMID: 12821738

9

Relating neocortical pathology to disability progression in multiple sclerosis using MRI.

Chen JT, Narayanan S, Collins DL, Smith SM, Matthews PM, Arnold DL. Chen JT, et al. Among authors: matthews pm. Neuroimage. 2004 Nov;23(3):1168-75. doi: 10.1016/j.neuroimage.2004.07.046. Neuroimage. 2004. PMID: 15528116 Clinical Trial.

10

Quantitative assessment of the reproducibility of functional activation measured with BOLD and MR perfusion imaging: implications for clinical trial design.

Tjandra T, Brooks JC, Figueiredo P, Wise R, Matthews PM, Tracey I. Tjandra T, et al. Among authors: matthews pm. Neuroimage. 2005 Aug 15;27(2):393-401. doi: 10.1016/j.neuroimage.2005.04.021. Neuroimage. 2005. PMID: 15921936 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters